BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35419479)

  • 1. The perfect PTEN - transcriptional regulation by PTEN dictates sarcoma identity.
    Langdon CG; Hatley ME
    Mol Cell Oncol; 2021; 8(6):2002120. PubMed ID: 35419479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
    Langdon CG; Gadek KE; Garcia MR; Evans MK; Reed KB; Bush M; Hanna JA; Drummond CJ; Maguire MC; Leavey PJ; Finkelstein D; Jin H; Schreiner PA; Rehg JE; Hatley ME
    Nat Commun; 2021 Sep; 12(1):5520. PubMed ID: 34535684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
    Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
    Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
    Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
    Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
    Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
    Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.
    Ouchi K; Miyachi M; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Iehara T; Hosoi H
    Cancer Cell Int; 2020; 20():192. PubMed ID: 32489328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma.
    Stefano S; Giovanni S
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of epigenetic alterations and in silico analysis of mutation affecting PTEN expression among Indian cervical cancer patients.
    Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Bin Hafeez Z; Tiwari RR; Wahabi K; Gandhi G; Alam Rizvi MM
    J Cell Biochem; 2019 Sep; 120(9):15851-15866. PubMed ID: 31074114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.
    Lu YM; Cheng F; Teng LS
    Sci Rep; 2016 Sep; 6():32723. PubMed ID: 27620353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAK Signaling in Rhabdomyosarcoma.
    Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
    Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
    Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
    Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion.
    Gumuskaya B; Gurel B; Fedor H; Tan HL; Weier CA; Hicks JL; Haffner MC; Lotan TL; De Marzo AM
    Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):209-15. PubMed ID: 23545904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.
    Krohn A; Diedler T; Burkhardt L; Mayer PS; De Silva C; Meyer-Kornblum M; Kötschau D; Tennstedt P; Huang J; Gerhäuser C; Mader M; Kurtz S; Sirma H; Saad F; Steuber T; Graefen M; Plass C; Sauter G; Simon R; Minner S; Schlomm T
    Am J Pathol; 2012 Aug; 181(2):401-12. PubMed ID: 22705054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of PTEN hypermethylation and breast cancer: a meta-analysis.
    Luo S; Chen J; Mo X
    Onco Targets Ther; 2016; 9():5643-50. PubMed ID: 27672335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
    Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
    Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of PTEN (Phosphatase and Tensin Homolog) in gastric cancer development and progression.
    Xu WT; Yang Z; Lu NH
    Asian Pac J Cancer Prev; 2014; 15(1):17-24. PubMed ID: 24528021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma.
    Pozzo E; Giarratana N; Sassi G; Elmastas M; Killian T; Wang CC; Marini V; Ronzoni F; Yustein J; Uyttebroeck A; Sampaolesi M
    Front Physiol; 2021; 12():701354. PubMed ID: 34421639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes.
    Vinciguerra M; Sgroi A; Veyrat-Durebex C; Rubbia-Brandt L; Buhler LH; Foti M
    Hepatology; 2009 Apr; 49(4):1176-84. PubMed ID: 19072831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer.
    Dirican E; Akkiprik M
    Tumour Biol; 2017 Mar; 39(3):1010428317695529. PubMed ID: 28351303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.